A T helper type 1 (Thl)-mediated colitis with similarities to inflammatory bowel disease in humans developed in severe combined immunodeficiency mice reconstituted with CD45R_B high CD4 + splenic T ceils and could be prevented by cotransfer ofCD45RB l~ CD4 + T cells. Inhibition of this Thl response by the CD45ILB l~ T cell population could be reversed in vivo by an anti-transforming growth factor (TGF) 13 antibody. Interleukin (IL) 4 was not required for either the differentiation or function of protective cells as CD45RB l~ CD4 + cells from IL-4-deficient mice were fully effective. These results identify a subpopulation of peripheral CD4 + cells and TGF-13 as critical components of the natural immune regulatory mechanism, which prevents the development of pathogenic Thl responses in the gut, and suggests that this immunoregulatory population is distinct from Th2 cells.
M
ucosal immune responses are highly regulated to al-.low activation of effector mechanisms that eliminate pathogenic microorganisms while specifically preventing cell-mediated inflammatory responses against dietary antigens and enteric flora. It has been suggested that a breakdown in this mucosal immune regulation is important in the development of idiopathic inflammatory bowel disease (IBD) in humans (1) . Dissection of the regulatory pathways that act normally to prevent the development of pathogenic immune responses in the intestine may therefore be key to the understanding of the pathogenesis of human IBD. We and others have described a model of colitis in mice that has proven useful for dissecting the mechanisms of this form of immune regulation. Colitis was induced in immunodeficient C.B-17 sdd mice by transfer of the CD45RB ~gh subset of CD4 + T cells from normal C.B-17 (2) or congenic BALB/c (3, 4) donors. Progressive colon inflammation was caused by a dysregulated Thl response as CD4 + T cells purified from the lamina propria of diseased mice produced very high levels of IFN-y, and TNF and disease was prevented by systemic treatment with antibodies to IFN-'y or TNF or with recombinant IL-10 (4). Significantly, transfer of the reciprocal CD45RB l~ population did not result in disease, and this population, when transferred together with CD45RBhighCD4 + T cells, completely inhibited disease development (3) (4) (5) . These data identify a subpopulation of CD4 + T cells, present in normal mice, that are critical for the regulation of pathogenic Thl responses in the gut.
It seems likely that the inhibition of colitis transferred by CD45RB l~ cells is mediated via the production of immunosuppressive cytokines. Th2 cells are known to inhibit Thl effector cell development and function, principally by the production of IL-4 and IL-10 (6-8). More recently, TGF-13 has been shown to be a mediator of the induced suppression associated with oral tolerance to foreign antigens (9, 10) . Such TGF-13-producing regulatory cells are often found together with Th2-1ike cells; however, it is not known whether these cells constitute part of the Th2 subset or represent a distinct subset of cells. Here, we use neutralizing anti-TGF-13 mAbs and IL-4-deficient mice to examine the role of these cytokines in the suppression of Thl-mediated colitis by CD45RBl~ + T ceils and to examine the relationship of regulatory cells to Th2 cells.
Materials and Methods
Mice. Specific pathogen-flee BALB/c and C.B-17 scid mice were obtained from Simonsen Laboratories (Gilroy, CA); 129/ SvEv mice were obtained from Taconic Farms, Inc. (Germantown, NY). Mice were maintained in the Animal Care Facility of the DNAX Research Institute. 129SvEv RAG-2-deficient mice and 129/J IL4T and 129 SvEv IL-4T (IL-4-deficient) mice were bred and maintained in the Animal Care Facility of the DNAX Research Institute. C.B-17 scid mice and P,-AG-2-deficient mice were housed in microisolator cages with sterile filtered air. Female mice were used at 8-12 wk of age.
Antibodies. The following mAbs were used for cell purification: AMS-32.1, anti-l-A d (PharMingen, San Diego, CA); 2-43, anti-mouse CD8 (TIB210; American Type Culture Collection, Rockville, MD); M1/70, anti-mouse Mac-1 (TIB128; American Type Culture Collection); RA3-6B2, anti-mouse B220 (11); FITC-conjugated 16A, anti-mouse CD45RB (PharMingen); PEconjugated anti-mouse CD4 (Becton Dickinson & Co., Mountain View, CA); and PE-conjugated isotype control mAb (PharMingen). The following mAbs were used in vivo: 1Dll. 16 (mouse IgG1), anti-TGFq31, 2, and 3 (12) , and 1410KG7 (mouse IgG1) isotype control rnAb (12) . For in vivo use, mAbs were purified by column chromatography from tissue culture supernatants. The resulting antibodies were >98% pure and contained <3 EU endotoxin per milligram of protein.
Cell Purification and Flow Cytofluorography. CD4 + T cell subsets were purified from the spleens of mice as previously described (3) . Briefly, cells were depleted of B220 +, MAC-1 +, I-A a+, and CD8 + cells by negative selection using sheep anti-rat-coated Dynabeads (Robbins Scientific Corp., Sunnyvale, CA). The remaining cells were labeled with FITC-conjugated anti-CD45RB (25 ~g/ml) and PE-conjugated anti-CD4 and fractionated into CD4+CD45RB high and CD4+CD45RB l~ fractions by two-color sorting on a FACSTAR | PLUS (Becton Dickinson & Co.). All populations were >98% pure on reanalysis.
Reconstitution of C.B-17 scid Mice with T Ceil Subpopulations. C.B-17 scid mice were injected intraperitoneally with 100 btl of PBS containing sorted CD4 + T cell subpopulations or unseparated CD4 + T cells. Anticytokine or control mAbs were injected intraperitoneally in PBS.
Microscopic Examination of Colons. Colons were removed from mice 8-18 wk after T cell reconstitution and fixed in PBS containing 10% formaldehyde. 6-p~m paraffin-embedded sections were cut and stained with hematoxilin and eosin. Microscopic sections were graded semiquantitatively as 0 (no change) to 5 (most severe) in a blinded fashion by the same pathologist (M.W. Leach).
Nucleic Acid Preparation and Semiquantitative PCR of Cytokine mRNA. Quantitation ofcytokine mRNA in the colon was performed as previously described (3). Briefly, RNA was prepared from 40-200-rag pieces of distal colon by a modification of the guanidium isothiocyanate method. 2-3 p~g of RNA from test samples was reverse transcribed using Superscriptase II RNAse H-reverse transcriptase (GIBCO BRL, Gaithersburg, MD). IFN-y, TNF-Ix, and hypoxanthine phosphoribosyl transferase (HPRT) cDNAs were amplified by PCR and detected by dot blot hybridization and phosphoimaging. Relative quantitation of samples was performed using quantitation of the housekeeping enzyme HPRT as an internal standard. HPRT levels in the samples were measured first, and samples with equivalent amounts of HPRT were then analyzed for cytokine cDNA. For each cytokine, the standard Th cDNA was run and specific cytokine levels were determined (IFN-3' 156 -1.2 pg, TNF-ci 10 -0.019 rig). Units of specific cytokine were determined for each sample by comparison with a standard curve constructed with cDNA from pooled RNA of an activated Thl and Th2 clone. 1 U ofcytokine was defined as the amount in l ng Th standard cDNA, and values were expressed as units of cytokine/105 U HPRT.
Results

Suppression of Colitis by CD45RB t~ CD4 + T Cells Is Dependent on TGF-fl.
In previous studies, mice restored with CD45RB high and CD45RBl~ + T cells remained protected from colitis when treated with anti-IL-4, anti-IL-10, or both mAbs (5), suggesting that suppression of colitis was mediated by other immunosuppressive cytokines. To test the role of TGF-[3, mice reconstituted with CD45R_Bhig h and CD45RBI~ + cells were treated with a mouse rnAb that neutralized TGF-[31, 2, and 3 (12) . In the initial experiments (Table 1 , protocol 1), mice were treated with 2 mg anti-TGF-[3 at the time ofreconstitution followed by 1 mg weekly for 6 wk and then killed for histological examination at 7 wk after transfer. Neutralization of TGF-[3 partially, but significantly, diminished the ability of CD45RB l~ T cells to protect from colitis. The average colitis score in these mice was 2, and 6 of 11 mice developed severe colitis compared with an average colitis score of 0.3 and zero incidence of severe colitis in isotype control-treated mice (Table 1, protocol 1). Anti-TGF-[3-treated mice that developed severe colitis also developed a wasting disease, indistinguishable from mice restored with CD45R_BhighCD4 + T cells alone (Table 1) . Anti-TGF-[3 treatment of unreconstituted scid mice (Table 1) or scid mice reconstituted only with CD45RBI~
+ T cells alone (data not shown) did not induce colitis or wasting, demonstrating that the antibody did not cause disease in the absence of the CD45R_B high population.
To address the possibility that insufficient antibody was being administered to inhibit TGF-[3 activity completely, the weekly dose of anti-TGF-[3 was doubled to 2 mg/wk in subsequent experiments (Table 1 , protocol 2). At this dose, 100% (7/7) of mice given a mixture of CD45RB high and CD45RB1~ + T cells developed severe colitis and wasting disease, a frequency indistinguishable from mice given CD45RBhighCD4 + T cells alone. The colitis in the two groups of mice was histologically identical (Fig. 1, A  and B) , being characterized by a prominent lymphocytic infiltrate, extensive epithelial cell hyperplasia, and goblet cell depletion. Mice given the mixture of CD45RB high and CD45RB l~ cells and treated with isotype control mAb were completely protected from these pathological changes (Fig. 1 C) .
Colitis Induced in Recipients of CD45RB h~eh and CD45RB l'w CD4 + T Cells Treated with Anti-TGF-fl Is Identical to Colitis
Induced by CD45RB h~h Cells Alone. Colitis induced by the CD45Pd3highCD4 + population has been shown to be a Thl response mediated by IFN-y and TNF (4). To determine whether the disease that developed in anti-TGF-~-treated mice restored with both CD45RBhig h and CD45RB l~ cells had a similar pathogenesis, colons were isolated from these mice 7 wk after T cell reconstitution and tested by reverse transcriptase-PCP,, analysis for the expression of IFN-y and TNF-ci mRNA (Fig. 2) . Mice restored with CD45R-B high cells and mice restored with CD45RB high and CD45RB l~ cells and treated with anti-TGF-[3 had 7-8-and 6-10-fold higher levels, respectively, of TNF-ci and IFN-y mRNA than mice protected from colitis by cotransfer of both T cell subsets. The extensive similarities in kinetics, histology, and cytokine mRNA expression between the diseases caused by CD45R.B high T cells without the regulatory population, and CD45RB h~gh T cells plus the regulatory population and anti-TGF-[3 demonstrate that TGF- [ 
+ T Cells Is Dependent on TGF-fl
Differentiation and Effector Function of the Regulatory CD45RB l~ Population Is IL-4 Independent. I n h i b i t i o n o f colitis by C D 4 5 R B j~ C D 4 + T cells was n o t b l o c k e d by administration o f a n t i -I L -4 m A b s (5), suggesting that IL-4 p r o d u c t i o n was n o t necessary for the TGF-13--dependent
regulatory m e c h a n i s m . H o w e v e r , these e x p e r i m e n t s did n o t establish w h e t h e r IL-4 was necessary for the d e v e l o p - (10), and some human Th2-1ike clones change to TGFq3-producing ceils when stimulated with altered peptide ligands (13) . IL-4 is the only known inducer of Th2 differentiation in mice (14, 15) , and a requirement for IL-4 in the development of regulatory CD45RB l~ ceils would provide additional support for a relationship between the two populations. To address this, CD45R.B l~ cells from IL-4-deficient and wild-type (WT) mice were compared for their ability to inhibit colitis induced by WT CD45RB high cells. As IL-4-deficient mice were available on the 129 but not the BALB/c background, RAG-2-deficient mice on the 129 background were used as immunodeficient recipients. The great majority of 1KAG-2-deficient mice restored with CD45R_B hlgh CD4 + T cells from syngeneic donors developed colitis very similar to that observed in C.B-17 scid mice (Table 2) . CD45RBl~ + T cells were present in both IL-4-deficient and WT mice (data not shown), and the populations from both mice were equally able to inhibit colitis and wasting disease. The average grade of colitis in the group reconstituted with IL-4-deficient cells was 0.8, and only 1 of 21 mice developed severe colitis (Table 2 ). In one experiment, neutralizing doses of the anti-IL-4 mAb 11Bll were administered weekly to mice reconstituted with CD45I~B high cells from WT donors and CD45KB l~ cells from IL-4-deficient mice to block any possible IL-4 production from sources other than the donor CD45R_B i~ population. These mice were still significantly protected from severe colitis (data not shown), demonstrating unambiguously that the regulatory population of CD45RB i~ ceils is present and mediates its immunoregulatory function in IL-4-deficient mice. 
Discussion
The experiments presented here identify a subpopulation ofCD4 + T cells that is present in normal mice and is essential for the prevention of Thl-mediated inflammation in the intestine. Inhibition of colitis by CD45RB l~ cells was completely ablated by an anti-TGF-[3 mAb, providing direct evidence that TGF-[3 is an important mediator of the natural immune regulatory mechanism involved in control of intestinal immune responses. Immunoregulatory subpopulations of CD4 § T cells that have the ability to inhibit the development of spontaneous organ-specific autoimmune diseases, including thyroiditis, gastritis, oophritis, and diabetes, have been identified in normal mice and rats; however, their mechanism of action has not been determined (16) (17) (18) . It is possible that TGF-I3 plays a similar role in this active mechanism of peripheral tolerance, as has been established here for the regulation of mucosal immune responses.
The suppression of Thl responses has been shown, in some instances, to be a property of Th2 cells, in part by production of IL-4 (5, 19, 20) . In this model of colitis, however, the protection could not be blocked by an anti-IL-4 mAb (5), and CD45RB l~ cells isolated from IL-4-deficient mice were able to protect from colitis as well as the same population isolated from WT mice. Taken together, these data indicate that the TGF-[3-dependent regulatory population both develops and functions normally in the absence of IL-4. Recently, similar forms of colitis have been shown to develop in TCR.-Ix chain-deficient mice (21), IL-2-deficient mice (22) , and IL-10-deficient mice (23), .among others, providing support for the idea that intestinal immune responses are regulated normally by a subpopulation of regulatory T cells (24) . Whether these other models are deficient in the TGF-[3-dependent regulation described here remains to be established.
There is now a large body of data correlating the induction of TGF-[3 with a subsequent state of antigen-specific systemic hyporesponsiveness induced by oral administration of antigen (25) . CD4 + T cell clones (10) and CD8 + populations (9) derived from mice fed myelin basic protein were able to inhibit the induction of active experimental allergic encephalomyelitis, a Thl-mediated autoimmune disease, by a mechanism that involved TGF-[3. Many of the regulatory CD4 + T cell clones also secreted IL-4 and IL-10; however, the roles of these cytokines in the regulatory activity of the clones were not tested. The present findings identify TGF-[3 as a key inhibitor of pathogenic Thl responses in a very different disease model and show the importance of this mode of regulation in normal mucosal unresponsiveness in vivo.
TGF-[31-deficient mice developed a severe multiple organ inflammatory disease that was lethal by 3-5 wk of age, with the most severe lesions being present in the heart and lungs (26, 27) . The cellular infiltration in affected organs was associated with increases in the inflammatory cytokines IFN-~/and TNF-ot (26) , suggesting that TGF-[31 is important for the prevention of dysregulated inflammatory responses in many organs. Interestingly, inflammation in the intestine of the TGF-[31-deficient mice was usually mild, although gastric inflammation was severe on some genetic backgrounds. These observations appear to be at odds with the findings from the scid transfer experiments, in which an absence of CD45RB l~ TGF-[3-dependent regulatory cells led to the development of severe inflammation restricted primarily to the colon. Mild inflammation was seen in the lung and stomach of some scid mice restored with CD45RBhighCD4 + T cells (3) . This difference may be related to (a) a strain dependency in the susceptibility of mice to develop colitis, or (b) the presence of TGF-[32 and TGF-[33 in TGF-[31-deficient mice, isoforms that would be inhibited in reconstituted scid mice treated with the mAb that neutralizes all three isoforms ofTGF-[3. TGF-[31, 2, and 3 have all been shown to be present in murine small and large intestine (28) , and it may be that TGF-[32 and TGF-[33 play a protective role in the intestine of TGF-[31-deficient mice.
In summary, the finding that suppression of colitis by CD45RB l~ cells was dependent on TGF-[3 but independent of IL-4 has provided valuable information on the mechanism of action of these natural regulatory cells. A thorough understanding of the development, effector function, and antigen specificity of these cells will provide a backbone of information with which to devise immune interventions favoring the development of TGF-[3-dependent regulatory cells rather than pathogenic Thl responses. Such immune therapy may be useful for treatment of a number of autoimmune diseases, including IBD.
